Inadequate and poor-quality outcome reporting in transplant clinical trials is a known barrier that impedes the ability of researchers to evaluate, replicate, synthesize, and build upon study findings and impacts evidence-based decision-making by patients, clinicians, and policy-makers. Using cardiovascular disease as an example, we will discuss and examine a set of evidence-informed and consensus-based standards focused on outcome reporting in clinical trials that can be applied across all solid organ transplantation.
Presentation: Defining cardiovascular outcomes in transplantation and the implications for trials design, John Gill, Canada
Live Q&A with John Gill, Canada
Presentation: Transparency in outcomes reporting clinical trials in transplantation, Jonathan C. Craig, Australia
Presentation: Patient engagement and transparency in outcomes reporting in transplantation, Allison Tong, Australia
Masterclass closing remarks